Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Pharmaceutical Sterility Testing Market

Pharmaceutical Sterility Testing Market Share

Report ID: GMI9112
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Pharmaceutical Sterility Testing Market Share

The pharmaceutical sterility testing industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Pharmaceutical Sterility Testing Market Companies

Prominent players operating in the pharmaceutical sterility testing industry include:

Alcami Corporation
bioMerieux SA
BA Sciences
Charles River Laboratories
Nelson Laboratories, LLC
Merck KGaA
Pacific BioLabs Inc.
Rapid Micro Biosystems Inc.
SGS Societe Generale de Surveillance SA.
STERIS Corporation
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Pharmaceutical sterility testing market size was USD 741.3 million in 2023 and is expected to register 10.8% CAGR from 2024-2032 owing to the increased demand for sterile products and biologics, such as vaccines and gene therapies worldwide.

The kits & reagents segment recorded 52.1% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to provide comprehensive and convenient solutions.

North America pharmaceutical sterility testing industry reached USD 317.3 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to a strong pharmaceutical industry and stringent regulatory environment in the region.

Charles River Laboratories, Nelson Laboratories, LLC, Merck KGaA, Pacific BioLabs Inc., Rapid Micro Biosystems Inc., SGS Soci